|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 35/17 | |||
| C07K 19/00 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3283520 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16714020.1 |
| Europos patento paraiškos padavimo data | 2016-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/051808 |
| Data | 2016-03-30 |
| (87) | Numeris | WO 2016/166630 |
| Data | 2016-10-20 |
| (30) | Numeris | Data | Šalis |
| 201562146825 P | 2015-04-13 | US | |
| 201662286473 P | 2016-01-25 | US | |
| 201662301177 P | 2016-02-29 | US |
| (72) |
KUO, Tracy Chia-Chien, US
CHAPARRO RIGGERS, Javier Fernando, US
SASU, Barbra Johnson, US
GALETTO, Roman, FR
BOLDAJIPOUR, Bijan Andre, US
SOMMER, Cesar Adolfo, US
VAN BLARCOM, Thomas John, US
PERTEL, Thomas Charles, US
RAJPAL, Arvind, US
DUCHATEAU, Philippe, FR
JUILLERAT, Alexandre, FR
VALTON, Julien, FR
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN |
| CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN |